V2676 15 mg (Dextroamphetamine Sulfate Extended-Release 15 mg)

Pill with imprint V2676 15 mg is Brown & Clear, Capsule-shape and has been identified as Dextroamphetamine Sulfate Extended-Release 15 mg. It is supplied by Par Pharmaceutical, Inc..

Dextroamphetamine is used in the treatment of adhd; narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dextroamphetamine 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for V2676 15 mg

Dextroamphetamine Sulfate Extended-Release

Imprint

V2676 15 mg

Strength

15 mg

Color

Brown & Clear

Size

16.00 mm

Shape

Capsule-shape

Availability

Prescription only

Drug Class

CNS stimulants

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

2 - High potential for abuse

Labeler / Supplier

Par Pharmaceutical, Inc.

Manufacturer

Vintage Pharmaceuticals, LLC

National Drug Code (NDC)

00603-2676

Inactive Ingredients

corn starch, dibutyl sebacate, ethylcellulose (10 mPa.s), hypromellose 2910 (50 mPa.s), magnesium stearate, polyethylene glycol 3350, sucrose, sodium lauryl sulfate, magnesium silicate, D&C Red No. 28, FD&C Blue No. 1, gelatin, titanium dioxide, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, povidone, propylene glycol, sodium hydroxide, shellac, D&C Yellow No. 10

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer